COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

Woman Killed in Pedestrian Crash at Road 26 and Avenue 17 1/2


Victim Was Pushing Shopping Cart, Hit by Teen in Fatal Madera Accident 

Madera, CA (April 12, 2020) – A woman killed in a pedestrian crash in Madera. The fatal accident occurred on the evening of April 12 at Road 26 and Avenue 17 1/2.

A 55-year-old woman from Susanville was pushing a shopping cart across the intersection when she was hit by a 19-year-old man. The driver fled the accident scene, claiming he did not know he had hit the woman. He saw the damage to his car and returned 30 minutes later. The woman died from her injuries.

#Madera

#93638


May 27, 2020

Boy Injured in Crash on Highway 168 Near Gooseberry Lane

Oscar Madrigal Arrested for DUI in Prather Accident...


May 11, 2020

Worker Killed When Electric Train System Collapses at LAX

Rebar Column Falls Down in Fatal Los Angeles Accident...


June 26, 2020

Pedestrian Killed in Crash on Warner Avenue

Man Hit by 2 Cars in Fatal Fountain Valley Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.